Deva.Is
DEVA.IS operates in the pharmaceuticals industry, focusing on the development, production, and distribution of pharmaceutical products.
Business. DEVA.IS operates in the pharmaceuticals industry, focusing on the development, production, and distribution of pharmaceutical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
DEVA.IS operates in the pharmaceuticals industry, focusing on the development, production, and distribution of pharmaceutical products.
DEVA.IS has a liquidity position that is characterized by a current ratio of 1.65, indicating that the company has sufficient current assets to cover its current liabilities. However, the company's free cash flow is negative at -1552917830.0, which suggests that it is spending more on capital expenditures than it is generating in operating cash flow. The company's cash and equivalents amount to 1641820260.0, which is less than its long-term debt of 5982582700.0, indicating a net cash outflow.
In terms of profitability, DEVA.IS has a return on equity of -0.0307 and a return on assets of -0.0214, both of which are negative, indicating that the company is not generating returns for its shareholders or assets. The operating income of 758145320.0 is significantly lower than the gross profit of 6304840920.0, suggesting high operating expenses or other costs that are eroding profitability.
The company's revenue is concentrated in a single segment, as no other segments are disclosed in the financial data. There is no information provided on geographic exposure, but the company's operations are likely concentrated in its home market given the lack of international revenue breakdown.
Looking at the growth trajectory, DEVA.IS has a net income of -806988480.0, indicating a loss for the period. The company's capital expenditure of -2364961430.0 suggests that it is investing in its operations, but the negative free cash flow indicates that these investments are not yet generating positive returns.
The risk assessment for DEVA.IS indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.23 is relatively low, but the negative net cash position after subtracting total debt is a concern. The company has not made any recent public filings or transcripts that would indicate significant changes in its business strategy or financial position.
- DEVA.IS has a negative return on equity and assets, indicating poor profitability.
- The company's liquidity position is moderate, with a current ratio of 1.65.
- DEVA.IS has a negative free cash flow, suggesting that it is spending more on capital expenditures than it is generating in operating cash flow.
- The company's debt-to-equity ratio is low, but its net cash position is negative after subtracting total debt.
- There is no information on geographic or segment diversification, indicating potential concentration risks.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- DEVA.IS Market data — financials · 2026-05-27